Clinical Trial Update: Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating mitochondrial dysfunction in bipolar disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Affective Disorder, Depression | Phase 2 | Status: WITHDRAWN